International Institute of Compassionate Care
  • Home
  • Mission | Aims
  • Who we are
    • Board of Directors
      • George Samoutis
      • Andreas Anastasiou
      • Theodoros Kyprianou
    • Scientific Committee
      • Dr Neophytos Stylianou
      • David Haslam
      • George Samoutis
      • Dr Sue Shea
      • Christos Lionis
      • Theodoros Kyprianou
      • Andreas Anastasiou
      • Renos Papadopoulos
      • Constantinos Phellas
      • Michela Tinelli
      • Ace Volkmann Simpson
      • Tony Rudd
      • Philippos Demetriou
    • Administration Committee
      • Dr Neophytos Stylianou
    • Academic Associates
      • Frank Röhricht
      • Ioanna Tsiligianni
      • Constantinos Paschalides
      • Costas Constantinou
      • Marios Constantinou
      • Maria M. Hadjimarkou
      • Alice Araujo
      • George Metsios
      • Yianna Ioannou
      • Evridiki Papastavrou
      • Marios Adonis
      • Stephen Smith
      • Kyriakos Markides
      • Kyriakos Souliotis
      • Paul Kymissis
      • Harry Anastasiou
      • Varnavas Panagiotou
      • Andreas Flouris
      • Vasileios Drakonakis
      • Zinonas Antoniou
    • Young Scientist Associates
      • Fanourios Georgiades
      • Andreas Samoutis
      • Demetra Kyprianou
      • Georgios Kourounis
      • Karolina Photiades
      • Priyanka Reddy
      • Sophronia Samouti
      • Gregoria Samouti
    • Compassionate Care Teams
      • NGH ICU Compassionate Care Team
  • Blog & Publications
    • Publications
    • Blog
    • IICC Video Gallery
    • Patient Education
    • COVID-19
  • News & Events
  • Testimonials
  • Join Us
  • Contact Us
  • Subscribe to our newsletter
COVID-19, Medication  /  April 14, 2020

ACE inhibitors, ARBs and Coronavirus

There have been concerns reported in the news recently about adverse effects of certain medication used to treat blood pressure and renal problems, raising the risk of infection from SARS-Cov-2 (the new coronavirus) and increasing the severity of the clinical symptoms.

What is the medication?

This relates to a specific type of medication called Angiotensin-Converting Enzyme inhibitors (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs).

ACE inhibitors include ramipril, lisinopril, enalapril. ARBs include losartan, candersartan and valsartan.

What is the current advice?

The Council on Hypertension of the European Society of Cardiology wish to highlight the lack of any evidence supporting harmful effect of ACE-I and ARB in the context of the pandemic COVID-19 outbreak. They strongly recommend that physicians and patients should continue treatment with their usual anti-hypertensive therapy because there is no clinical or scientific evidence to suggest that treatment with ACEi or ARBs should be discontinued because of the Covid-19 infection. [1]

This is supported by other Professional Societies, who have released similar supporting statements, such as the International Society of Hypertension [2] and the Renal Association UK who advise people taking these medications to continue to take them.[3]

What does this mean for me?

The situation is always changing with new research and evidence coming to light. Advice may change in the future. However current advice from 17th March 2020 is for patients to continue with their usual ACE inhibitors or ARBs. Stopping the medication can lead to worsening of pre-existing conditions and is not recommended. If you have any concerns, please discuss with your Personal Doctor.

References

[1]Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers.13 Mar 2020. Prof. Giovanni de Simone, Chair, ESC Council on Hypertension, On behalf of the Nucleus Members

[2] A statement from the International Society of Hypertension on COVID-19, 16th March 2020

[3] The Renal Association, UK position statement for patients: novel corona virus infection and the use of blood pressure medications, 15th March 2020

[4] Sparks MA, Hiremath S et al. “The Coronavirus Conundrum: ACE2 and Hypertension Edition” NephJC http://www.nephjc.com/news/covidace2 accessed March 17, 2020

Δρ Αίμιλη Ηρακλέους

Προσωπικος Ιατρος ΓΕΣΥ

Ιατρικό Κέντρο “Ο Απόστολος Λουκάς”

Διαβάστε το βιογραφικό της Δρ Αίμιλης Ηρακλέους.

Post navigation

Expert reaction to reports that the French Health Minister recommended use of paracetamol for fever from COVID-19 rather than ibuprofen or cortisone
Κτηριακή αναβάθμιση της Ιεράς Μονής Οσίου Γρηγορίου Αγίου Όρους

Share your thoughts Cancel reply

Your email address will not be published. Required fields are marked *

Follow us

  • Facebook
Copyright © 2020 International Institute for Compassionate Care.
All Rights Reserved.
  • Elara by LyraThemes